Literature DB >> 15700216

The relationship between apoptosis and non-alcoholic fatty liver disease: an evolutionary cornerstone turned pathogenic.

A Canbay1, R K Gieseler, G J Gores, G Gerken.   

Abstract

The data currently available favor a model for the pathogenesis of non-alcoholic fatty liver disease that is based on an apparent sequential relationship of intrahepatic apoptosis, inflammation and fibrogenesis. Based on both hepatic and peripheral insulin resistance, the hepatocellular accumulation of triglycerides, termed steatosis, initially leads to an altered metabolism of glucose and free fatty acids in the liver. In response, increased expression of death receptors in simple steatosis enhances the hepatocytes' susceptibility for pro-apoptotic stimuli, thus eliciting excessive hepatocyte apoptosis and inflammation. Evidence indicates that these processes, if prolonged, activate both hepatic stellate and Kupffer cells, thus leading to a vicious circle in which apoptosis, inflammation, cellular activation, and collagen deposition are upregulated even further.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15700216     DOI: 10.1055/s-2004-813744

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  7 in total

1.  Effectors of alcohol-induced cell killing in Drosophila.

Authors:  P Chen; X Tu; F Akdemir; S K Chew; A Rothenfluh; J M Abrams
Journal:  Cell Death Differ       Date:  2012-04-27       Impact factor: 15.828

2.  Smad7 dependent expression signature highlights BMP2 and HK2 signaling in HSC transdifferentiation.

Authors:  Bernd Denecke; Lucia Wickert; Yan Liu; Loredana Ciuclan; Steven Dooley; Nadja M Meindl-Beinker
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

3.  Resveratrol amplifies profibrogenic effects of free fatty acids on human hepatic stellate cells.

Authors:  Lars P Bechmann; Denis Zahn; Robert K Gieseler; Christian D Fingas; Guido Marquitan; Christoph Jochum; Guido Gerken; Scott L Friedman; Ali Canbay
Journal:  Hepatol Res       Date:  2009-01-14       Impact factor: 4.288

4.  TNFR1 determines progression of chronic liver injury in the IKKγ/Nemo genetic model.

Authors:  F J Cubero; A Singh; E Borkham-Kamphorst; Y A Nevzorova; M Al Masaoudi; U Haas; M V Boekschoten; N Gassler; R Weiskirchen; M Muller; C Liedtke; C Trautwein
Journal:  Cell Death Differ       Date:  2013-08-09       Impact factor: 15.828

5.  Heme oxygenase-1 prevents non-alcoholic steatohepatitis through suppressing hepatocyte apoptosis in mice.

Authors:  YueMin Nan; RongQi Wang; SuXian Zhao; Fang Han; Wen Juan Wu; LingBo Kong; Na Fu; Li Kong; Jun Yu
Journal:  Lipids Health Dis       Date:  2010-10-28       Impact factor: 3.876

6.  Novel algorithm for non-invasive assessment of fibrosis in NAFLD.

Authors:  Jan-Peter Sowa; Dominik Heider; Lars Peter Bechmann; Guido Gerken; Daniel Hoffmann; Ali Canbay
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

7.  Sphingosine 1-Phosphate Receptor Blockade Affects Pro-Inflammatory Bone Marrow-Derived Macrophages and Relieves Mouse Fatty Liver Injury.

Authors:  Jingjing Yang; Na Chang; Le Yang; Xiaofang Ji; Xuan Zhou; Lei Tian; Yuehan Ma; Yuanru Yang; Yuran Liu; Lin Yang; Liying Li
Journal:  Int J Mol Sci       Date:  2019-09-22       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.